In addition, the most used immunohistochemical markers in the differential diagnosis of endometrial stromal neoplasms, i.e., CD10, is also positive in a significant percentage (almost half) of UTROSCT cases [1,9,24,25]. The gene discussed is MME; the disease is endometrial stromal tumor.